Biomarker analysis of circulating tumor DNA in clinical stage III melanoma patients treated with neoadjuvant immunotherapy combined with targeted therapy.
Saved in:
| Title: | Biomarker analysis of circulating tumor DNA in clinical stage III melanoma patients treated with neoadjuvant immunotherapy combined with targeted therapy. |
|---|---|
| Authors: | Stoff R; Department of Oncology, Mayo Clinic, Guggenheim 3-23, Rochester, MN 55905, USA., Routman DM; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA., Yalon M; Department of Radiology, Mayo Clinic, Rochester, MN, USA., Bogan AW; Division of Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ, USA., Block MS; Department of Oncology, Mayo Clinic, Rochester, MN, USA., Hieken TJ; Department of Surgery, Mayo Clinic, Rochester, MN, USA. |
| Source: | Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2026 Jan 19; Vol. 18, pp. 17588359251412729. Date of Electronic Publication: 2026 Jan 19 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
